Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

SOPHiA GENETICS (SOPH) Shares Outstanding (Weighted Average) (2020 - 2025)

SOPHiA GENETICS's Shares Outstanding (Weighted Average) history spans 6 years, with the latest figure at $4.8 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 14.95% to $4.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.8 million, a 14.95% increase, with the full-year FY2025 number at $4.8 million, up 14.95% from a year prior.
  • Shares Outstanding (Weighted Average) hit $4.8 million in Q4 2025 for SOPHiA GENETICS, up from $4.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for SOPH hit a ceiling of $64.8 million in Q4 2023 and a floor of $590.0 in Q2 2025.
  • Historically, Shares Outstanding (Weighted Average) has averaged $18.8 million across 5 years, with a median of $4.2 million in 2024.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): soared 541150.0% in 2022 and later crashed 99.99% in 2025.
  • Tracing SOPH's Shares Outstanding (Weighted Average) over 5 years: stood at $55.3 million in 2021, then grew by 15.91% to $64.1 million in 2022, then increased by 1.02% to $64.8 million in 2023, then tumbled by 93.53% to $4.2 million in 2024, then increased by 14.95% to $4.8 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for SOPH at $4.8 million in Q4 2025, $4.2 million in Q3 2025, and $590.0 in Q2 2025.